MYOV: Myovant Sciences Ltd Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) n/a
Enterprise Value ($M) n/a
Book Value ($M) n/a
Book Value / Share n/a
Price / Book n/a
NCAV ($M) 0.00
NCAV / Share n/a
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) n/a
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio n/a
Current Ratio n/a

Balance Sheet (mrq) ($M)
Current Assets n/a
Assets n/a
Liabilities n/a
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue n/a
Operating Income n/a
Net Income n/a
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations n/a
Cash from Investing n/a
Cash from Financing n/a

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-10 13D/A Sumitomo Chemical Co., Ltd. 100.00 -8.48
02-17 13G Alpine Global Management, LLC 6.60
02-14 13G/A Bb Biotech Ag 6.00 -4.07
02-09 13G/A Janus Henderson Group Plc 1.20 -78.70
02-09 13G FIL Ltd 8.91
02-06 13G/A Wellington Management Group Llp 0.01 -99.88

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2023-01-26 10-Q Table of Contents
2022-10-26 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One)

(click for more detail)

Similar Companies
LCI – Lannett Co., Inc. LLY – Lilly(Eli) & Co
MRK – Merck & Co Inc NUVB – Nuvation Bio Inc – Class A
OGN – Organon & Co.


Financial data and stock pages provided by
Fintel.io